Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.88%82.95M | 1.80%80.75M | 3.22%78.99M | 139.75%321.67M | 147.78%84.41M | 145.77%81.41M | 131.00%79.33M | 134.48%76.53M | -65.07%134.17M | -65.54%34.06M |
| Cost of revenue | -11.91%24.41M | -7.73%20.79M | 0.67%20.22M | 220.69%90.56M | 341.24%15.43M | 893.75%27.71M | 552.92%22.54M | 490.71%20.08M | -86.40%28.24M | -93.80%3.5M |
| Gross profit | 9.00%58.54M | 5.58%59.96M | 4.12%58.77M | 118.18%231.11M | 125.64%68.97M | 77.02%53.7M | 83.85%56.79M | 93.06%56.45M | -40.01%105.93M | -27.90%30.57M |
| Operating expense | 13.88%15.58M | 10.20%15.8M | -4.59%17.11M | 370.87%66.1M | 119.83%24.96M | 153.76%13.68M | 140.14%14.33M | 179.08%17.93M | -64.57%14.04M | 32.27%11.35M |
| Staff costs | 0.44%5.72M | 6.10%5.91M | 13.06%5.64M | 293.93%21.81M | 251.69%5.56M | 469.29%5.69M | 255.14%5.57M | 259.47%4.98M | -17.16%5.54M | -1.98%1.58M |
| Depreciation and amortization | --351.52K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Depreciation | --351.52K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other operating expenses | 19.05%9.51M | 12.80%9.89M | -11.38%11.47M | 420.96%44.3M | 98.49%19.4M | 81.92%7.99M | 99.20%8.77M | 156.95%12.95M | -69.67%8.5M | 66.82%9.77M |
| Operating profit | 7.33%42.95M | 4.02%44.16M | 8.17%41.66M | 79.57%165.01M | 129.08%44.01M | 60.43%40.02M | 70.37%42.46M | 68.83%38.51M | -32.90%91.89M | -43.18%19.21M |
| Net non-operating interest income (expenses) | -0.77%-30.26M | 7.50%-28.25M | 5.34%-29.97M | -140.61%-138.44M | -84.48%-30.89M | -121.26%-30.03M | -128.66%-30.54M | -221.23%-31.66M | 59.28%-57.54M | 54.74%-16.74M |
| Non-operating interest income | 14.70%4.71M | 52.77%6.19M | 59.53%4.56M | ---- | 1,273.20%3.71M | 494.73%4.1M | 434.96%4.05M | 93.84%2.86M | ---- | -90.22%270.13K |
| Non-operating interest expense | 1.44%34.98M | -0.28%34.41M | -0.35%34.48M | 144.50%138.2M | 105.98%34.6M | 141.69%34.48M | 144.43%34.51M | 205.19%34.6M | -62.24%56.52M | -57.37%16.8M |
| Total other finance cost | 95.29%-16.71K | -61.45%34.6K | 150.66%44.59K | -76.13%242.33K | -102.58%-5.53K | -4,411.26%-354.59K | 5,087.22%89.77K | -877.98%-88.02K | 54.01%1.01M | -37.78%214.66K |
| Net investment income | 371.92%15.06M | 3.19M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -68.03%261.82K | 818.98K | ||||||||
| Income before tax | 27.03%12.69M | 33.54%15.91M | 70.56%11.69M | 9.20%41.89M | 431.42%13.12M | -12.15%9.99M | 3.04%11.91M | -47.08%6.86M | 985.55%38.36M | 177.69%2.47M |
| Income tax | 239.76%2.94M | 5.15%8.29M | 70.57%8.13M | -86.30%15.33M | -63.71%4.78M | -129.90%-2.1M | 356.22%7.88M | -94.97%4.77M | 1,112.09%111.85M | 1,580.74%13.17M |
| Net income | -19.31%9.76M | 89.05%7.62M | 70.52%3.56M | 136.15%26.57M | 178.02%8.35M | 178.06%12.09M | -72.46%4.03M | 102.55%2.09M | -441.94%-73.49M | -169.97%-10.7M |
| Net income continuous operations | -19.31%9.76M | 89.05%7.62M | 70.52%3.56M | 136.15%26.57M | 178.02%8.35M | 178.06%12.09M | -72.46%4.03M | 102.55%2.09M | -441.94%-73.49M | -169.97%-10.7M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -19.31%9.76M | 89.05%7.62M | 70.52%3.56M | 136.15%26.57M | 178.02%8.35M | 178.06%12.09M | -72.46%4.03M | 102.55%2.09M | -551.34%-73.49M | -220.21%-10.7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.31%9.76M | 89.05%7.62M | 70.52%3.56M | 136.15%26.57M | 178.02%8.35M | 178.06%12.09M | -72.46%4.03M | 102.55%2.09M | -551.34%-73.49M | -220.21%-10.7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.09%0.0089 | 86.49%0.0069 | 68.42%0.0032 | 136.22%0.0242 | 178.15%0.0076 | 178.20%0.011 | -72.20%0.0037 | 102.56%0.0019 | -551.35%-0.0668 | -220.22%-0.0097 |
| Diluted earnings per share | -19.09%0.0089 | 86.49%0.0069 | 68.42%0.0032 | 136.22%0.0242 | 178.15%0.0076 | 178.20%0.011 | -72.20%0.0037 | 102.56%0.0019 | -551.35%-0.0668 | -220.22%-0.0097 |
| Dividend per share | 0.00%0.0318 | 0 | 0.0318 | 0.0318 | 0 | 0.0318 | ||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.